The Billionaire, the Psychedelics and the Best-Selling Memoirnews2025-09-24T07:00:18+00:00September 24th, 2025|The New York Times|
¿Una pastilla para curar el cerebro? Un grupo de científicos intenta probarlanews2025-09-06T09:02:12+00:00September 6th, 2025|The New York Times|
How Rick Perry Became a Fervent Advocate for the Psychedelic Ibogainenews2025-08-11T18:19:05+00:00August 11th, 2025|The New York Times|
Sarepta Refuses FDA Request to Stop Shipping Muscular Dystrophy Drug Elevidysnews2025-07-19T00:53:42+00:00July 19th, 2025|The New York Times|
Texas OK’s $50 Million for Ibogaine Researchnews2025-06-14T19:18:02+00:00June 14th, 2025|The New York Times|
Kennedy Says ‘Charlatans’ Are No Reason to Block Unproven Stem Cell Treatmentsnews2025-06-05T16:07:54+00:00June 5th, 2025|The New York Times|
Psychiatric Drugs: Getting Off vs. Staying Onnews2025-03-21T20:02:58+00:00March 21st, 2025|The New York Times|
How an Activist Group Helped Torpedo MDMA Therapynews2025-02-04T08:00:10+00:00February 4th, 2025|The New York Times|